CN111518660A - Health-care white spirit with effect of relieving alcoholic brain injury and preparation method thereof - Google Patents
Health-care white spirit with effect of relieving alcoholic brain injury and preparation method thereof Download PDFInfo
- Publication number
- CN111518660A CN111518660A CN202010354374.9A CN202010354374A CN111518660A CN 111518660 A CN111518660 A CN 111518660A CN 202010354374 A CN202010354374 A CN 202010354374A CN 111518660 A CN111518660 A CN 111518660A
- Authority
- CN
- China
- Prior art keywords
- extraction
- extract
- solvent
- white spirit
- extracting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 208000029028 brain injury Diseases 0.000 title claims abstract description 17
- 230000001476 alcoholic effect Effects 0.000 title claims abstract description 15
- 230000000694 effects Effects 0.000 title description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 108
- 238000000605 extraction Methods 0.000 claims description 62
- 239000000284 extract Substances 0.000 claims description 56
- 239000007788 liquid Substances 0.000 claims description 40
- 239000002904 solvent Substances 0.000 claims description 37
- 244000130270 Fagopyrum tataricum Species 0.000 claims description 27
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- 150000004676 glycans Chemical class 0.000 claims description 26
- 229920001282 polysaccharide Polymers 0.000 claims description 26
- 239000005017 polysaccharide Substances 0.000 claims description 26
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 26
- 238000010992 reflux Methods 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 22
- 240000002234 Allium sativum Species 0.000 claims description 21
- 235000004611 garlic Nutrition 0.000 claims description 21
- 230000036541 health Effects 0.000 claims description 16
- 244000046146 Pueraria lobata Species 0.000 claims description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 15
- 238000000108 ultra-filtration Methods 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 14
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 13
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 13
- 229960003080 taurine Drugs 0.000 claims description 13
- 239000000945 filler Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229940104640 chinese yam extract Drugs 0.000 claims description 11
- 239000012467 final product Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 238000001694 spray drying Methods 0.000 claims description 9
- 238000001291 vacuum drying Methods 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 244000241838 Lycium barbarum Species 0.000 claims description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 5
- 244000182216 Mimusops elengi Species 0.000 claims description 5
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 5
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 5
- 235000004879 dioscorea Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 4
- 230000001376 precipitating effect Effects 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000005238 degreasing Methods 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 239000003205 fragrance Substances 0.000 abstract description 3
- 235000019441 ethanol Nutrition 0.000 description 47
- 235000014101 wine Nutrition 0.000 description 22
- 230000006378 damage Effects 0.000 description 11
- 230000035622 drinking Effects 0.000 description 11
- 102000019197 Superoxide Dismutase Human genes 0.000 description 8
- 108010012715 Superoxide dismutase Proteins 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 5
- 229940118019 malondialdehyde Drugs 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 4
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 4
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 206010013781 dry mouth Diseases 0.000 description 4
- 230000007954 hypoxia Effects 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 208000014644 Brain disease Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 230000006931 brain damage Effects 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001713 cholinergic effect Effects 0.000 description 2
- 208000010877 cognitive disease Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000022540 Consciousness disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 208000006264 Korsakoff syndrome Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000027382 Mental deterioration Diseases 0.000 description 1
- 206010027374 Mental impairment Diseases 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 201000008485 Wernicke-Korsakoff syndrome Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 235000021167 banquet Nutrition 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003492 excitotoxic effect Effects 0.000 description 1
- 231100000063 excitotoxicity Toxicity 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000001760 fusel oil Substances 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
- C12G3/055—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides extracted from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Compared with the traditional white spirit, the white spirit prepared by the preparation method has more complex flavor components, more elegant fragrance, better taste and better function of relieving alcoholic brain injury.
Description
Technical Field
The invention relates to the technical field of health-care white spirit preparation, and particularly relates to health-care white spirit with an effect of relieving alcoholic brain injury and a preparation method thereof.
Background
In recent years, the damage caused by drinking and alcohol abuse is becoming a global medical and social problem, drinking and injuring the liver is becoming a common recognition of people as smoking and injuring the lung, but most people are not aware of the fact, and the damage to other organs of the human body, such as the brain, is large due to excessive drinking. After entering human body, ethanol can be directly absorbed into blood through gastric mucosa and quickly enters brain through blood brain barrier. It has been reported that part of people with chronic alcohol addiction have atrophy of cerebral cortex and part of people have signs of mental deterioration. The cerebral cortex of a person who drinks for a long time is in an anesthetic state, so that the person is in abnormal speech, unconscious and unconscious, namely the folk custom called 'wine numbness', and the fact that the long-term subacute alcohol intake can cause the Korsakoff syndrome and seriously damages the learning and memory is not contended.
Alcohol affects various systems of the human body, and can cause injury even after long-term abuse, particularly to the central nervous system, which not only causes organic lesion, but also causes consciousness and mental disorder. Some parts of the brain have been reported to be more vulnerable to alcohol than other parts, such as basal ganglia, hippocampus, reticulum activation system, etc. The experimental results show that the lipid peroxide content (MDA) of the brain cell membrane of the rat is obviously increased and the activity of superoxide dismutase (SOD) is obviously reduced when the small dose of alcohol is fed for a long time, which indicates that after the small dose of alcohol is fed for a certain time, a large amount of oxygen free radicals are generated in brain tissues to form dynamic balance disorder between oxidation and oxidation resistance, and the free radicals of the brain tissues are increased due to long-term drinking of the small dose of alcohol to attack the phospholipid of the central nervous system membrane to cause peroxidation damage; the reduced levels of SOD may be associated with a large consumption of oxygenated free radicals, while lipid peroxides may inhibit SOD activity, resulting in a diminished body's oxidative capacity.
The lack of certain essential nutrient elements due to long-term drinking is a potential factor for alcohol-induced brain damage. Thiamine is a required accessory molecule for the 3 enzymes involved in the two pathways of carbohydrate metabolism. Reduction of thiamine levels can affect many cellular functions, resulting in severe brain disorders. The research result shows that the alcohol enters the blood to reduce the vitamin B1, so that the function of enzyme production in the human body is reduced, which is also a reason for the damage of the brain. Wernike's encephalopathy is also a common manifestation of alcohol-drinking brain injury, accounting for about 3% of chronic alcohol-toxic diseases.
The proper drinking of the wine can play a role in protecting blood vessels and heart, but the middle or large amount of drinking of the wine can reduce the function of the A-type receptor of the neuron aminobutyric acid, cause brain dysfunction and damage to the cranial nerves to a certain extent.
At present, many studies on the repair of alcoholic brain injury have been reported. Research shows that the garlic polysaccharide can antagonize the mouse learning and memory reduction and brain cell damage caused by continuous excessive drinking through regulating cholinergic and monoamine nervous systems. It has also been shown that tocopherol can improve cognitive dysfunction in rats caused by chronic alcohol by reducing acetylcholinesterase activity and the level of oxidative stress in the central nervous system. Research reports that the lycium barbarum polysaccharide has a protection effect on the hypoxia injury of neurons, can obviously improve the form change of the hypoxia injury neurons, improve the cell survival rate, reduce the leakage of intracellular LDH (lactate dehydrogenase), obviously improve the activity of intracellular SOD (superoxide dismutase) and reduce the generation of lipid peroxidation products MDA (malondialdehyde).
For people who have to attend various business banquet occasions frequently, excessive alcohol intake caused by long-term drinking is more likely to cause alcoholic brain injury. If the health care white spirit product which can meet the commercial drinking requirement and relieve alcoholic brain injury and even tonify the brain is provided, the health care white spirit product is certainly welcomed.
Disclosure of Invention
The invention aims to develop the health care white spirit which can meet the commercial drinking requirement, relieve the brain injury caused by alcohol and simultaneously has certain auxiliary effect of reducing the liver injury.
The technical scheme of the invention is as follows:
a health care white spirit with the efficacy of relieving alcoholic brain injury is prepared by adding the following raw materials into 50 kiloliters of base spirit: 18-30 kg of tartary buckwheat extracting solution, 4-6 kg of garlic polysaccharide, 2-3.5 kg of kudzu root extract, 2-4 kg of Chinese yam extract, 1-2.5 kg of medlar extract, 1-2.5 kg of chrysanthemum extract, 0.5-1.5 kg of taurine and 0.5-1.5 kg of citric acid.
Preferably, 25 kg of tartary buckwheat extracting solution, 5kg of garlic polysaccharide, 2.5 kg of kudzu root extract, 2.5 kg of Chinese yam extract, 1.5 kg of medlar extract, 1.5 kg of chrysanthemum extract, 1 kg of taurine and 1 kg of citric acid.
Preferably, the base wine is a wine base brewed by using tartary buckwheat.
Preferably, the tartary buckwheat extracting solution is obtained by digitally extracting tartary buckwheat from Sichuan Liangshan tartary buckwheat, and the extracting process is as follows:
1 addition of solvent
The extraction tank was filled with 60% ethanol as an extraction solvent.
2 thermal refluxing
The extraction temperature is 60 +/-10 ℃, a steam valve is opened, heating is carried out, and the temperature is raised to carry out hot reflux extraction. Timing when the temperature reaches 60 ℃, extracting for the first time for 1-3 hours, and transferring the extracting solution into an extracting solution storage tank after the extraction is finished.
3 repeating the extraction
Repeating the above operations, extracting the residue twice, the solvent amount is 1.0 + -0.5 times of the filler amount, the second extraction time is 1-2 hr, the third extraction time is 1 hr, extracting for 3 times, and discharging the residue from the bottom of the extraction tank after the extraction of the medicinal materials is finished.
4 centrifugation
Filtering the extractive solution with half-frame filter or high-speed centrifuging with disc centrifuge, wherein the disc centrifugation parameters are as follows: the feeding speed is less than or equal to 15000L/h, the slag discharge time is 10-30 minutes, the centrifuged liquid medicine is required to be clear and transparent, clear liquid is collected, and the centrifuged sediment is discarded.
5 concentrating
Transferring the separated liquid into a double-effect concentrator for concentration until the concentration of crude drug is 1.5 + -0.5 kg/L, wherein the concentration temperature is not more than 75 deg.C.
6 solid-liquid separation
The centrifugal rotating speed is required to be less than or equal to 1500 rpm, and the aperture of the filter cloth is required to be less than or equal to 1000 meshes.
7 ultrafiltration membrane filtration
Passing the clear liquid through ultrafiltration membrane with large molecular weight, and collecting the trapped liquid to obtain radix Et rhizoma Fagopyri Tatarici extract.
Preferably, the garlic polysaccharide is prepared by the following steps:
1 crushing
The garlic is peeled, crushed and mashed.
2 extraction of
Adding distilled water according to the ratio of material to liquid of 1:10, and heating and refluxing.
3 separation of
After the leaching, the mixture enters a centrifuge, and is centrifuged for 20 minutes at 4000 rpm, and supernatant is taken.
4 concentration
And transferring the supernatant into a double-effect concentrator for concentration.
5 alcohol precipitation
Adding anhydrous ethanol of 4 deg.C into the concentrated solution, stirring while adding until the final ethanol concentration is 70%, and precipitating with ethanol at low temperature for 6 hr.
6 drying
Drying at 55 deg.C to obtain the final product.
Preferably, the yam extract is prepared by the following steps:
1 crushing and degreasing
Pulverizing dried rhizoma Dioscoreae into 40 mesh, and placing into extraction tank. And adding the treated solvent into the extraction tank, wherein the dosage of the solvent is 80% ethanol which is 2-3 times of the amount of the filler. Extracting for 2 times after refluxing for 2-3 hours, filtering, and reserving the precipitate for the next step of extracting effective components.
2 extraction of
Adding distilled water according to the ratio of 1:15, leaching for 3 hr, filtering the extractive solution, extracting repeatedly for 1 time under the same conditions, and mixing extractive solutions.
3 vacuum concentration
Concentration was performed in vacuo using a rotary evaporator.
4 precipitation
Adding 95% ethanol until the ethanol concentration is 70%, and separating out rhizoma Dioscoreae polysaccharide.
5 Freeze drying
Washing rhizoma Dioscoreae polysaccharide with anhydrous ethanol for several times, dissolving in water, and freeze drying.
Preferably, the preparation steps of the kudzu root extract are as follows:
adding solvent into the extraction tank, wherein the solvent is 50% ethanol and the amount of the solvent is 20 times of that of the filler. Soaking for ≧ 10h, extracting at 80 deg.C, refluxing for 3h, separating out residue, adding 20 times of 50% ethanol, heating and refluxing for 3h, mixing extractive solutions, and filtering. Passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
Preferably, the preparation steps of the wolfberry extract are as follows:
adding solvent into the extraction tank, wherein the solvent is 15 times of water of the medicinal materials, the extraction temperature is 80-90 deg.C, and reflux extracting for 3 times, each time for 1 hr. Filtering, passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
Preferably, the preparation steps of the chrysanthemum extract are as follows:
adding solvent into the extraction tank, wherein the solvent is 80% ethanol and the amount of the solvent is 12 times of that of the filler. The extraction temperature is 60 deg.C, and reflux extraction is carried out for 2 times, 1 time for 40 min. Filtering, passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
The invention also provides a preparation method of the white spirit, which comprises the steps of adding the base wine, the tartary buckwheat extracting solution, the garlic polysaccharide, the radix puerariae extract, the Chinese yam extract, the wolfberry fruit extract, the chrysanthemum extract, the taurine and the citric acid in proportion, fully and uniformly stirring, standing for 48 hours, and filtering to obtain the yellowish transparent health-care white spirit. Compared with the prior art, the technical scheme of the invention at least has the following beneficial effects:
1. the beverage wine is obtained by adding the active ingredients such as the tartary buckwheat extract, the yam extract, the garlic polysaccharide and the like into the high-quality tartary buckwheat wine base, and the active ingredients are effectively and accurately extracted by adopting a specific extraction process and are well preserved.
2. The research on the health-care white spirit for assisting in relieving alcoholic brain injury belongs to the first time, and the health-care white spirit not only has the flavor and the taste of the traditional white spirit, but also has the functions of assisting in relieving the alcoholic brain injury, assisting in reducing the liver injury and the like.
Drawings
FIG. 1 is a process flow diagram of the present invention.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The tartary buckwheat is rich in various active ingredients such as tartary buckwheat flavone, the flavonoid substances have the effects of resisting oxidation, reducing blood fat, reducing blood pressure and reducing blood sugar, belong to alcohol-soluble substances, have good solubility in white spirit and can promote the absorption of the flavonoid substances by a human body. Meanwhile, the tartary buckwheat grains contain rich calcium, phosphorus, magnesium and potassium, trace elements such as iron, copper, zinc and manganese, and also contain selenium which is a trace element not contained in other cereals and necessary for human bodies. Selenium has functions of protecting myocardium and preventing cardiovascular system diseases; selenium also has effects of promoting brain development, and preventing neurodegenerative diseases such as Alzheimer disease and Parkinson syndrome.
The kudzu root is used as a traditional medicine-food dual-purpose plant in China, and the puerarin is one of main drug effect components. Modern pharmacological studies show that the kudzuvine root and the puerarin both have obvious brain protection activity and have protection effect on model animals or cells such as Alzheimer disease, Parkinson disease, stroke and the like.
Research reports that the lycium barbarum polysaccharide has a protection effect on the hypoxia injury of neurons, can obviously improve the form change of the hypoxia injury neurons, improve the cell survival rate, reduce the leakage of intracellular LDH (lactate dehydrogenase), obviously improve the activity of intracellular SOD (superoxide dismutase) and reduce the generation of lipid peroxidation products MDA (malondialdehyde).
The garlic polysaccharide is an effective active ingredient extracted from garlic, belongs to fructan of inulin, and has the effects of resisting oxidation and virus, regulating blood fat, reducing blood sugar and improving liver injury caused by CCL 4. Studies such as Chencui peach and the like show that the garlic polysaccharide can antagonize the mouse learning and memory reduction and brain cell injury caused by continuous excessive drinking by regulating cholinergic and monoamine nervous systems.
Taurine is used as neurotransmitter, neuromodulator, antioxidant and anti-inflammatory factor, and has a large amount of cell protection factors. Can exert neuroprotective effect by resisting apoptosis, resisting oxidative stress, resisting inflammation, inhibiting glutamate induced excitotoxicity, etc., and can prevent age-related cognitive function decline by supplementing taurine in small amount for a long time. In clinical practice, taurine has been widely used in cardiovascular diseases, alzheimer's disease and alcoholism.
Therefore, the invention takes the tartary buckwheat, the kudzuvine root, the medlar and the Chinese yam as raw materials to develop the alcoholic brain injury relieving alcoholic beverage wine. The brewing experiment is carried out by tartary buckwheat, and the brewed wine base is detected, and the result is as follows:
TABLE 1 test results of Tartary buckwheat wine base
As can be seen from table 1: the tartary buckwheat raw material contains a large amount of bioflavonoids and contains some trace elements such as: potassium, magnesium and amino acids, and has good health promotion effect. However, the main functional components of the tartary buckwheat and the kudzuvine root cannot enter the raw wine and most of the main functional components are lost due to the processes of fermentation and distillation, so that the white wine directly brewed hardly has functions.
The invention determines a technical route of extracting effective substances by only adopting a specific extraction technology, matching active ingredients such as garlic polysaccharide and the like, and simultaneously adding a certain proportion of tartary buckwheat extract and a proper amount of taurine and citric acid for combination. Meanwhile, the difficult problem of solubility of the garlic polysaccharide is solved through an enzymolysis process, and finally, the flavor of the white spirit is blended, so that the product has the attribute of the white spirit and the function of relieving alcoholic brain injury is provided for drinkers.
Referring to fig. 1, the preparation method of the present application is as follows:
1 preparation process of tartary buckwheat extracting solution
1.1 addition of solvent
The extraction tank was filled with 60% ethanol as an extraction solvent.
1.2 thermal refluxing
The extraction temperature is 60 +/-10 ℃, a steam valve is opened, heating is carried out, and the temperature is raised to carry out hot reflux extraction. Timing when the temperature reaches 60 ℃, extracting for the first time, wherein the extraction time is 1-3 hours. After extraction, the extract is transferred to an extract storage tank.
1.3 repeated extraction
Repeating the above operations, extracting the residue twice, wherein the solvent amount is 1.0 + -0.5 times of the filler amount, the second extraction time is 1-2 hr, and the third extraction time is 1 hr, and extracting for 3 times. After the extraction of the medicinal materials is finished, the medicine residues are discharged from the bottom of the extraction tank.
1.4 centrifugation
Filtering the extractive solution with half-frame filter or high-speed centrifuging with disc centrifuge, wherein the disc centrifugation parameters are as follows: the feeding speed is less than or equal to 15000L/h, the slag discharge time is 10-30 minutes, the centrifuged liquid medicine is required to be clear and transparent, clear liquid is collected, and the centrifuged sediment is discarded.
1.5 concentration
Transferring the separated liquid into a double-effect concentrator for concentration until the concentration of crude drug is 1.5 + -0.5 kg/L, wherein the concentration temperature is not more than 75 deg.C.
1.6 solid-liquid separation
The centrifugal rotating speed is required to be less than or equal to 1500 rpm, and the aperture of the filter cloth is required to be less than or equal to 1000 meshes.
1.7 Ultrafiltration Membrane filtration
Passing the clear liquid through ultrafiltration membrane with large molecular weight, and collecting the trapped liquid to obtain radix Et rhizoma Fagopyri Tatarici extract.
2 preparation process of garlic polysaccharide
2.1 peeling the crushed garlic, crushing and mashing into mud.
2.2 adding distilled water into the extract according to the ratio of the material to the liquid of 1:10, and heating and refluxing.
2.3 after the separation and extraction, the mixture enters into a centrifuge, and is centrifuged for 20 minutes at 4000 rpm, and supernatant is taken.
2.4 concentration the supernatant is transferred to a double-effect concentrator for concentration.
2.5 Alcoholisation to the concentrate was added 4 ℃ absolute ethanol, stirred while adding, until the end point was 70% ethanol concentration, and low temperature alcoolation was carried out for 6 hours.
2.6 drying at 55 deg.C.
3 preparation process of Chinese yam extract
3.1 pulverizing and defatting dried rhizoma Dioscoreae into 40 mesh powder, and placing into extraction tank. And adding the treated solvent into the extraction tank, wherein the dosage of the solvent is 80% ethanol which is 2-3 times of the amount of the filler. Extracting for 2 times after refluxing for 2-3 hours, filtering, and reserving the precipitate for the next step of extracting effective components.
3.2 adding distilled water into the extract according to the ratio of the materials to the liquid of 1:15, extracting for 3 hours, filtering the extract, repeatedly extracting for 1 time according to the same condition, and combining the extract.
3.3 vacuum concentration was performed using a rotary evaporator.
3.4 precipitating, adding 95% ethanol until the ethanol concentration is 70%, and precipitating rhizoma Dioscoreae polysaccharide.
3.5 freeze-drying, washing the yam polysaccharide with absolute ethyl alcohol for multiple times, adding water for dissolving, and freeze-drying to obtain the yam polysaccharide.
4 preparation process of radix puerariae extract
Adding solvent into the extraction tank, wherein the amount of the solvent is 20 times of the amount of 50% ethanol in the filler. Soaking for ≧ 10h, extracting at 80 deg.C, refluxing for 3h, separating out residue, adding 20 times of 50% ethanol, heating and refluxing for 3h, mixing extractive solutions, and filtering. Passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
5 preparation process of fructus Lycii extract
Adding solvent into the extraction tank, wherein the solvent is 15 times of water of the medicinal materials, the extraction temperature is 80-90 deg.C, and reflux extracting for 3 times, each time for 1 hr. Filtering, passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
6 preparation process of chrysanthemum extract
Adding solvent into the extraction tank, wherein the amount of the solvent is 80% ethanol which is 12 times of the amount of the filler. The extraction temperature is 60 deg.C, and reflux extraction is carried out for 2 times, 1 time for 40 min. Filtering, passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
7 preparation process of health-care white spirit for assisting in relieving alcoholic brain injury
Selecting 50 kiloliters of high-quality tartary buckwheat wine base, adding 25 kilograms of tartary buckwheat extract, 5 kilograms of garlic polysaccharide, 2.5 kilograms of kudzu root extract, 2.5 kilograms of Chinese yam extract, 1.5 kilograms of medlar extract, 1.5 kilograms of chrysanthemum extract and 1 part of taurine and citric acid respectively, fully and uniformly stirring, standing for 48 hours, filtering to obtain yellowish transparent health wine, filtering and filling to obtain the finished wine. The product is characterized in that: the wine is clear and light yellow, the medicine fragrance is fragrant, the wine body is soft, sweet and refreshing, the fragrance is harmonious, and the aftertaste is refreshing and clean.
The wine body is subjected to trace component detection, and the result is as follows:
TABLE 2 test results of health-promoting Chinese liquor
Detecting items | Content, mg/L | Detecting items | Content, mg/L |
Total Flavonoids | 182.8 | Puerarin and its preparation method | 34.6 |
Linoleic acid | Not detected out | Lycium barbarum polysaccharides | 18.1 |
Potassium salt | 43.1 | Betaine | 216.4 |
Magnesium alloy | 19.8 | Oleanolic acid | 2.6 |
Methanol | 60 | Cystine | Not detected out |
Fusel oil | 560 | Tyrosine | Not detected out |
Lead (II) | <0.02mg/L | Valine | Not detected out |
Manganese oxide | <0.02mg/L | Methionine | Not detected out |
Arginine | Not detected out | Alanine | Not detected out |
Threonine | Not detected out | Proline | Not detected out |
Aspartic acid | Not detected out | Lysine | Not detected out |
Serine | Not detected out | Isoleucine | Not detected out |
Glycine | Not detected out | Leucine | Not detected out |
Histidine | Not detected out | Phenylalanine | Not detected out |
Meanwhile, the wine body is proved to be safe and nontoxic through animal experiments of Jinpai company; and animal experiments show that: the speed of the upper head of the control group mouse is far higher than that of the experimental group mouse, namely the health care white spirit has the effect of reducing alcoholic injury to a certain extent. The results are shown in tables 3-4.
TABLE 3 wine body preparation and administration information
Numbering | Sample information | Alcohol content (% vol) | Gavage volume (ml/10g) | Remarks for note |
1# | 42 degree alcohol | 42 | 0.15 | |
2# | Alcohol + betaine | 42 | 0.15 | |
3# | Alcohol + kudzu root extract | 42 | 0.15 | |
4# | Alcohol and lycium barbarum polysaccharide | 42 | 0.15 | |
5# | Alcohol, betaine and lycium barbarum polysaccharide | 42 | 0.15 | |
6# | The invention | 42 | 0.15 | |
7# | Alcohol, betaine, kudzu vine root extract and wolfberry polysaccharide | 42 | 0.15 | |
8# | Alcohol + Chinese yam extract | 42 | 0.15 | |
9# | Alcohol + garlic polysaccharide extract | 42 | 0.15 | |
10# | Alcohol + chrysanthemum extract | 42 | 0.15 | |
11# | Alcohol + taurine | 42 | 0.15 | |
12# | Alcohol + citric acid | 42 | 0.15 | |
13# | Alcohol and tartary buckwheat extracting solution | 42 | 0.15 |
Table 4 formula after drinking drunkenness degree contrast study results (n is 12, 13)
Note: "x" compared to the 42 degree alcohol group, p < 0.01; "" compared to the 42 alcohol group, p < 0.05. The test data shows that: under the same alcohol intake, the drunkenness and the dry mouth degree of the wine are reduced after drinking, which shows that the drunkenness and the dry mouth degree of the wine can be reduced by adding the kudzu root extract, the lycium barbarum polysaccharide and the taurine; the alcohol + radix puerariae extract, the alcohol + Chinese yam extract and the alcohol + chrysanthemum extract group have the effects of reducing the drunkenness degree and the dry mouth degree after being drunk, and the results show that the addition of the radix puerariae extract, the Chinese yam extract and the chrysanthemum extract has the effects of reducing the drunkenness degree and reducing the dry mouth degree.
Claims (10)
1. A health care white spirit with the efficacy of relieving alcoholic brain injury is characterized in that the white spirit is prepared by adding the following raw materials in 50 kiloliters of base spirit: 18-30 kg of tartary buckwheat extracting solution, 4-6 kg of garlic polysaccharide, 2-3.5 kg of kudzu root extract, 2-4 kg of Chinese yam extract, 1-2.5 kg of medlar extract, 1-2.5 kg of chrysanthemum extract, 0.5-1.5 kg of taurine and 0.5-1.5 kg of citric acid.
2. The health white spirit according to claim 1, wherein the tartary buckwheat extract is 25 kg, the garlic polysaccharide is 5kg, the kudzu vine root extract is 2.5 kg, the Chinese yam extract is 2.5 kg, the wolfberry fruit extract is 1.5 kg, the chrysanthemum extract is 1.5 kg, the taurine is 1 kg, and the citric acid is 1 kg.
3. The health white spirit according to claim 1, wherein the base spirit is a raw spirit brewed from tartary buckwheat.
4. The health-care white spirit according to claim 1, characterized in that the process of the tartary buckwheat extracting solution is as follows:
1 addition of solvent
The extraction tank was filled with 60% ethanol as an extraction solvent.
2 thermal refluxing
The extraction temperature is 60 +/-10 ℃, a steam valve is opened, heating is carried out, and the temperature is raised to carry out hot reflux extraction. Timing when the temperature reaches 60 ℃, extracting for the first time for 1-3 hours, and transferring the extracting solution into an extracting solution storage tank after the extraction is finished.
3 repeating the extraction
Repeating the above operations, extracting the residue twice, the solvent amount is 1.0 + -0.5 times of the filler amount, the second extraction time is 1-2 hr, the third extraction time is 1 hr, extracting for 3 times, and discharging the residue from the bottom of the extraction tank after the extraction of the medicinal materials is finished.
4 centrifugation
Filtering the extractive solution with half-frame filter or high-speed centrifuging with disc centrifuge, wherein the disc centrifugation parameters are as follows: the feeding speed is less than or equal to 15000L/h, the slag discharge time is 10-30 minutes, the centrifuged liquid medicine is required to be clear and transparent, clear liquid is collected, and the centrifuged sediment is discarded.
5 concentrating
Transferring the separated liquid into a double-effect concentrator for concentration until the concentration of crude drug is 1.5 + -0.5 kg/L, wherein the concentration temperature is not more than 75 deg.C.
6 solid-liquid separation
The centrifugal rotating speed is required to be less than or equal to 1500 rpm, and the aperture of the filter cloth is required to be less than or equal to 1000 meshes.
7 ultrafiltration membrane filtration
Passing the clear liquid through ultrafiltration membrane with large molecular weight, and collecting the trapped liquid to obtain radix Et rhizoma Fagopyri Tatarici extract.
5. The health white spirit according to claim 1, wherein the garlic polysaccharide is prepared by the following steps:
1 crushing
The garlic is peeled, crushed and mashed.
2 extraction of
Adding distilled water according to the ratio of material to liquid of 1:10, and heating and refluxing.
3 separation of
After the leaching, the mixture enters a centrifuge, and is centrifuged for 20 minutes at 4000 rpm, and supernatant is taken.
4 concentration
And transferring the supernatant into a double-effect concentrator for concentration.
5 alcohol precipitation
Adding anhydrous ethanol of 4 deg.C into the concentrated solution, stirring while adding until the final ethanol concentration is 70%, and precipitating with ethanol at low temperature for 6 hr.
6 drying
Drying at 55 deg.C to obtain the final product.
6. The health white spirit according to claim 1, wherein the yam extract is prepared by the following steps:
1 crushing and degreasing
Pulverizing dried rhizoma Dioscoreae into 40 mesh, and placing into extraction tank. And adding the treated solvent into the extraction tank, wherein the dosage of the solvent is 80% ethanol which is 2-3 times of the amount of the filler. Extracting for 2 times after refluxing for 2-3 hours, filtering, and reserving the precipitate for the next step of extracting effective components.
2 extraction of
Adding distilled water according to the ratio of 1:15, leaching for 3 hr, filtering the extractive solution, extracting repeatedly for 1 time under the same conditions, and mixing extractive solutions.
3 vacuum concentration
Concentration was performed in vacuo using a rotary evaporator.
4 precipitation
Adding 95% ethanol until the ethanol concentration is 70%, and separating out rhizoma Dioscoreae polysaccharide.
5 Freeze drying
Washing rhizoma Dioscoreae polysaccharide with anhydrous ethanol for several times, dissolving in water, and freeze drying.
7. The health white spirit according to claim 1, wherein the kudzu root extract is prepared by the following steps:
adding solvent into the extraction tank, wherein the solvent is 50% ethanol and the amount of the solvent is 20 times of that of the filler. Soaking for ≧ 10h, extracting at 80 deg.C, refluxing for 3h, separating out residue, adding 20 times of 50% ethanol, heating and refluxing for 3h, mixing extractive solutions, and filtering. Passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
8. The health white spirit according to claim 1, wherein the preparation of the wolfberry fruit extract comprises the following steps:
adding solvent into the extraction tank, wherein the solvent is 15 times of water of the medicinal materials, the extraction temperature is 80-90 deg.C, and reflux extracting for 3 times, each time for 1 hr. Filtering, passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
9. The health white spirit according to claim 1, wherein the chrysanthemum extract is prepared by the following steps:
adding solvent into the extraction tank, wherein the solvent is 80% ethanol and the amount of the solvent is 12 times of that of the filler. The extraction temperature is 60 deg.C, and reflux extraction is carried out for 2 times, 1 time for 40 min. Filtering, passing the clear liquid through an ultrafiltration membrane with large molecular weight, and collecting the trapped liquid. Concentrating the trapped fluid, and spray drying or vacuum drying to obtain the final product.
10. The method for preparing health white spirit according to any one of claims 1 to 9, characterized in that the method comprises adding base spirit, tartary buckwheat extract, garlic polysaccharide, kudzu root extract, Chinese yam extract, wolfberry fruit extract, chrysanthemum extract, taurine and citric acid in proportion, fully stirring uniformly, standing for 48 hours, and filtering to obtain yellowish transparent health white spirit.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010354374.9A CN111518660A (en) | 2020-04-29 | 2020-04-29 | Health-care white spirit with effect of relieving alcoholic brain injury and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010354374.9A CN111518660A (en) | 2020-04-29 | 2020-04-29 | Health-care white spirit with effect of relieving alcoholic brain injury and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111518660A true CN111518660A (en) | 2020-08-11 |
Family
ID=71903563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010354374.9A Pending CN111518660A (en) | 2020-04-29 | 2020-04-29 | Health-care white spirit with effect of relieving alcoholic brain injury and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111518660A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113293081A (en) * | 2021-06-30 | 2021-08-24 | 中国石油天然气股份有限公司青海润滑油销售分公司 | Combined white spirit |
CN115011433A (en) * | 2022-07-23 | 2022-09-06 | 劲牌有限公司 | Liqueur for relieving alcoholic brain injury and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103059151A (en) * | 2011-10-22 | 2013-04-24 | 徐玮 | Process for extracting water-soluble polysaccharide of Chinese yam |
CN104069187A (en) * | 2014-07-24 | 2014-10-01 | 劲牌生物医药有限公司 | Technological method extracting duckwheat flavone from duckwheat |
CN105381306A (en) * | 2015-12-17 | 2016-03-09 | 湖南东蒙生物科技有限公司 | Teabag composition capable of relieving alcoholic liver, brain and heart injuries |
CN108531341A (en) * | 2018-07-17 | 2018-09-14 | 劲牌有限公司 | A kind of health-care spirit and preparation method thereof for having effects that auxiliary and alleviating gout |
CN108840957A (en) * | 2018-05-31 | 2018-11-20 | 合肥昂诺新材料有限公司 | A kind of extraction and purification process of garlic polysaccharide |
-
2020
- 2020-04-29 CN CN202010354374.9A patent/CN111518660A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103059151A (en) * | 2011-10-22 | 2013-04-24 | 徐玮 | Process for extracting water-soluble polysaccharide of Chinese yam |
CN104069187A (en) * | 2014-07-24 | 2014-10-01 | 劲牌生物医药有限公司 | Technological method extracting duckwheat flavone from duckwheat |
CN105381306A (en) * | 2015-12-17 | 2016-03-09 | 湖南东蒙生物科技有限公司 | Teabag composition capable of relieving alcoholic liver, brain and heart injuries |
CN108840957A (en) * | 2018-05-31 | 2018-11-20 | 合肥昂诺新材料有限公司 | A kind of extraction and purification process of garlic polysaccharide |
CN108531341A (en) * | 2018-07-17 | 2018-09-14 | 劲牌有限公司 | A kind of health-care spirit and preparation method thereof for having effects that auxiliary and alleviating gout |
Non-Patent Citations (3)
Title |
---|
彭啸宇等: "山药多糖对大鼠脑缺血再灌注损伤的保护作用", 《中药药理与临床》 * |
童国强等: "毛铺苦荞酒缓解酒精性脑损伤作用机理研究", 《酿酒科技》 * |
陈翠桃等: "大蒜多糖对慢性酒精中毒小鼠学习记忆能力的影响", 《吉林大学学报(医学版)》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113293081A (en) * | 2021-06-30 | 2021-08-24 | 中国石油天然气股份有限公司青海润滑油销售分公司 | Combined white spirit |
CN115011433A (en) * | 2022-07-23 | 2022-09-06 | 劲牌有限公司 | Liqueur for relieving alcoholic brain injury and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101301094B1 (en) | Composition for relieving hangover or improving liver function | |
JP6053873B2 (en) | Saponin bioavailability enhancing composition | |
CN105767397A (en) | Spleen-invigorating and stomach-harmonizing gingko tea | |
CN108201138A (en) | A kind of preparation and preparation method thereof of relieving alcoholism and protecting liver composition, composition | |
CN111518660A (en) | Health-care white spirit with effect of relieving alcoholic brain injury and preparation method thereof | |
CN102742906A (en) | Momordica grosvenori drink with low glycemic index and anti-fatigue action | |
CN110897147A (en) | Dendrobium officinale alcohol-dispelling and liver-protecting composition and preparation method thereof | |
CN109601795A (en) | Using penthorum chinense pursh as composition alcohol-decomposing beverage of primary raw material and preparation method thereof | |
CN108041357B (en) | Natural plant multifunctional nutritional beverage and preparation method thereof | |
CN101463314B (en) | Non-intoxicated liquor and preparation of antialcoholism nutrient fluid therefor | |
CN116458565B (en) | Coffee bean extract and preparation method thereof | |
KR101525478B1 (en) | Food composition for relieving hangover | |
CN103725555A (en) | Wild banana and oxhorn banana health-care wine for assisting blood pressure reduction and preparation method thereof | |
CN108143787A (en) | A kind of preparation method of the compound flavones of pueraria lobata, hoveniae semoveniae semen | |
CN107019136A (en) | A kind of solid beverage with effect of lowering blood sugar and preparation method thereof | |
KR102235563B1 (en) | Composition for fatigue recovery and sexual function improvement containing high content of arginine | |
JP4822474B2 (en) | Health drink manufacturing method | |
KR102433586B1 (en) | Food composition for relieving hangover and improving hepatic function | |
KR101088711B1 (en) | A composition for prevention or alleviation of obesity containing Astragalus membranaceus extract manufactured by using enzymatic hydrolysis | |
KR102429921B1 (en) | Fermented Black Ginseng extract including alcoholic liver injury prevention functional ingredients and method for manufacturing it | |
CN110551598B (en) | Vinegar paste and vinegar aging accelerating and concentrating method and application | |
CN110669623A (en) | Chrysanthemum health wine and preparation method thereof | |
KR20090098254A (en) | Method for producing artemisia extract by fermentation | |
KR102491278B1 (en) | Food composition including red ginseng and arginine, and a method of preparing the same | |
KR102702485B1 (en) | Composition for preventing, ameliorating or treating retinal disease comprising Achyranthis Radix extract or its fraction as effective component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200811 |